Background Ginkgo biloba extract EGb 761® and pentoxifylline are frequently prescribed for the treatment of tinnitus. Objective To compare the treatment effects of Ginkgo biloba extract EGb 761R and pentoxifylline. Setting The study was performed at Department of Otorhinolaryngology of University Hospital Královské Vinohrady and 3rd Medical Faculty, Charles University in Prague. Method Patients with sub-chronic or chronic tinnitus were enrolled in double-blind trial and randomized to receive 120 mg EGb 761® or 600 mg pentoxifylline, each twice a day and in double-dummy fashion over a 12-week period. Main outcome measure changes in 11-Point Box Scales for tinnitus loudness and annoyance, the abridged Tinnitus Questionnaire (Mini-TQ), the Hospital Anxiety and Depression Scale (HADS), and the Sheehan Disability Scale (SDS). Results Full analysis set for efficacy analysis comprised 197 patients (EGb 761®, 99; pentoxifylline 98). For both treatment groups, significant improvements were observed in the Mini-TQ, the 11-Point Box Scales for tinnitus loudness and annoyance, the HADS anxiety score and the SDS. There was no relevant difference with regard to tinnitus-related outcomes between the two treatment groups. 20 adverse events were documented in EGb 761® group and 36 adverse events were reported for pentoxifylline group. No serious adverse event was reported during the study. Conclusion EGb 761® and pentoxifylline were similarly effective in reducing the loudness and annoyance of tinnitus as well as overall suffering of the patients. The incidence of adverse events was lower in the EGb 761® group.

3rd Faculty of Medicine Charles University Prague Czech Republic

Department of Otorhinolaryngology University Hospital Kralovske Vinohrady Šrobárova 50 10034 Prague Czech Republic

Int J Clin Pharm. 2018 Oct;40(5):1409. doi: 10.1007/s11096-018-0704-y. PubMed

Zobrazit více v PubMed

Langguth B, Kreuzer PM, Kleinjung T, De Ridder D. Tinnitus: causes and clinical management. Lancet Neurol. 2013;12:920–930. doi: 10.1016/S1474-4422(13)70160-1. PubMed DOI

Lockwood AH, Salvi RJ, Burkard RF. Tinnitus. N Engl J Med. 2002;347:904–910. doi: 10.1056/NEJMra013395. PubMed DOI

Bhatt JM, Harrison WL, Bhattacharyya N. Prevalence, severity, exposures, and treatment patterns of tinnitus in the United States. JAMA Otolaryngol Head Neck Surg. 2016;142:959–965. doi: 10.1001/jamaoto.2016.1700. PubMed DOI PMC

Nondahl DM, Cruickshanks KJ, Wiley TL, Klein BEK, Klein R, Chappell R, Tweed TS. The 10-year incidence of tinnitus among older adults. Int J Audiol. 2010;49:580–585. doi: 10.3109/14992021003753508. PubMed DOI PMC

Stockdale D, McFerran D, Brazier P, Pritchard C, Kay T, Dowrick C, Hoare DJ. An economic evaluation of the healthcare cost of tinnitus management in the UK. BMC Health Serv Res. 2017;17:577. doi: 10.1186/s12913-017-2527-2. PubMed DOI PMC

Salviati M, Bersani FS, Terlizzi S, Melcore C, Panico R, Romano GF, Valeriani G, Macrì F, Altissimi G, Mazzei F, Testungini V, Latini L, Delle Chiaie R, Biondi M, Cianfrone G. Tinnitus: clinical experience of the psychosomatic connection. Neuropsychiatr Dis Treat. 2014;10:267–275. PubMed PMC

Hallam RS, Jakes SC, Hinchcliffe R. Cognitive variables in tinnitus annoyance. Br J Clin Psychol. 1988;27:213–222. doi: 10.1111/j.2044-8260.1988.tb00778.x. PubMed DOI

Baguley D, McFerran D, Hall D. Tinnitus. Lancet. 2013;382:1600–1607. doi: 10.1016/S0140-6736(13)60142-7. PubMed DOI

ICH International Conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. Good clinical practice: consolidated guideline. Geneva: ICH; 1996.

Hiller W, Goebel G. Rapid assessment of tinnitus-related psychological distress using the Mini-TQ. Int J Audiol. 2004;43:600–604. doi: 10.1080/14992020400050077. PubMed DOI

Hallam RS. Manual of the Tinnitus Questionnaire (TQ) London: Psychological Corporation; 1996.

Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x. PubMed DOI

Herrmann C. International experiences with the Hospital Anxiety and Depression Scale—a review of validation data and clinical results. J Psychosom Res. 1997;42:17–41. doi: 10.1016/S0022-3999(96)00216-4. PubMed DOI

Sheehan DV, Harnett-Sheehan K, Raj BA. The measurement of disability. Int Clin Psychopharmacol. 1996;11(Suppl 3):89–95. doi: 10.1097/00004850-199606003-00015. PubMed DOI

Langguth B, Salvi R, Elgoyhen AB. Emerging pharmacotherapy of tinnitus. Expert Opin Emerg Drugs. 2009;14:687–702. doi: 10.1517/14728210903206975. PubMed DOI PMC

Maass B, Silberzahn J, Simon R. Effects of Ginkgo biloba extract (Tebonin) on hydrogen washout from the cochlea base under hypotensive ischaemia [Zur Wirkung von Ginkgo-biloba-Extrakt (Tebonin) auf die Wasserstoff-Auswaschvorgänge an der Cochleabasis unter hypotensiver Ischämie.] Extracta Otorhinolaryngologica. 1987;9:169–172.

Erdinçler DS, Karakoç Y, Toplan S, Önen S, Sukyasyan A, Beğer T, Demiroğlu Ç. The effect of Ginkgo biloba glycoside on the blood viscosity and erythrocyte deformability. Clin Hemorheol. 1996;16:271–276.

Coleman JK, Quirk WS, Dengerink HA, Wright JW. Pentoxifylline increases cochlear blood flow while decreasing blood pressure in guinea pigs. Hear Res. 1990;47:169–174. doi: 10.1016/0378-5955(90)90174-N. PubMed DOI

Woelk H, Arnoldt KH, Kieser M, Hoerr R. Ginkgo biloba special extract EGb 761® in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial. J Psychiatr Res. 2007;41:472–480. doi: 10.1016/j.jpsychires.2006.05.004. PubMed DOI

Ramassamy C, Christen Y, Clostre F, Costentin J. The Ginkgo biloba extract, EGb 761®, increases synaptosomal uptake of 5-hydroxytryptamine: in vitro and ex vivo studies. J Pharm Pharmacol. 1992;44:943–945. doi: 10.1111/j.2042-7158.1992.tb03244.x. PubMed DOI

Stocksmeier U, Eberlein M. Depressed mood associated with impaired cerebral function. Efficacy of a Ginkgo biloba extract assessed in double-blind study. [Depressive Verstimmung bei Hirnleistungsstörungen. Wirkung eines Ginkgo-biloba-Extraktes in Doppelblind-Studie überprüft.] TW Neurologie Psychiatrie. 1992;6:74–76.

Tchantchou F, Lacor PN, Cao Z, Lao L, Hou Y, Cui C, Klein WL, Luo Y. Stimulation of neurogenesis and synaptogenesis by bilobalide and quercetin via common final pathway in hippocampal neurons. J Alzheimers Dis. 2009;18:787–798. doi: 10.3233/JAD-2009-1189. PubMed DOI

Biesinger E, Kipman U, Schätz S, Langguth B. Qigong for the treatment of tinnitus: a prospective randomized controlled study. J Psychosom Res. 2010;69:299–304. doi: 10.1016/j.jpsychores.2010.04.013. PubMed DOI

Frank G, Kleinjung T, Landgrebe M, Vielsmeier V, Steffenhagen C, Burger J, Frank E, Vollberg G, Hajak G, Langguth B. Left temporal low-frequency rTMS for the treatment of tinnitus: clinical predictors of treatment outcome—a retrospective study. Eur J Neurol. 2010;17:951–956. doi: 10.1111/j.1468-1331.2010.02956.x. PubMed DOI

von Boetticher A. Ginkgo biloba extract in the treatment of tinnitus: a systematic review. Neuropsychiatr Dis Treat. 2011;7:441–447. doi: 10.2147/NDT.S22793. PubMed DOI PMC

Biesinger E, Heiden C, Greimel V, Lendle T, Höing R, Albegger K. Strategies in ambulatory treatment of tinnitus [Strategien in der ambulanten Behandlung des Tinnitus.] HNO. 1998;46:157–169. doi: 10.1007/s001060050215. PubMed DOI

Cesarone MR, Incandela L, Belcaro G, De Sanctis MT, Nicolaides AN, Griffin M, Geroulakos G, Ramaswami G. Treatment of vascular inner ear disease in vascular patients with pentoxifylline: a controlled, randomized trial. Angiology. 2002;53(Suppl 1):S23–S26. PubMed